We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+18.4%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.28B
AUM Growth
+$253M
Cap. Flow
+$143M
Cap. Flow %
11.17%
Top 10 Hldgs %
13.47%
Holding
1,446
New
471
Increased
321
Reduced
302
Closed
327

Top Buys

Rank Stock Value
1
VRNA
Verona Pharma
VRNA
+$16.8M
2
U icon
Unity
U
+$14M
3
AIFC
AI Financial Corp
AIFC
+$13.8M
4
CYBR
CyberArk
CYBR
+$12.6M
5
NSC icon
Norfolk Southern
NSC
+$11.7M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$13.2M
2
TSLA icon
Tesla
TSLA
+$12.9M
3
BIDU icon
Baidu
BIDU
+$11.9M
4
HYG icon
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
+$10M
5
AMED
Amedisys
AMED
+$8.89M

Sector Composition

Rank Sector Weight
1 Technology 21.32%
2 Communication Services 11.38%
3 Healthcare 11.08%
4 Consumer Discretionary 10.37%
5 Financials 9.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPB icon
501
Spectrum Brands
SPB
$2.02B
$510K 0.04%
9,702
+3,290
+51% +$182K
PPLI
502
People Inc
PPLI
$3.03B
$509K 0.04%
+14,930
New +$557K
IMRX icon
503
Immuneering
IMRX
$293M
$507K 0.04%
+72,467
New +$376K
DAVE icon
504
Dave Inc
DAVE
$3.94B
$506K 0.04%
2,537
+1,063
+72% +$230K
EEM icon
505
iShares MSCI Emerging Markets ETF
EEM
$29.8B
$505K 0.04%
9,466
-2,534
-21% -$127K
SNDX icon
506
Syndax Pharmaceuticals
SNDX
$1.82B
$504K 0.04%
32,739
-57,094
-64% -$747K
MAS icon
507
Masco
MAS
$14.7B
$499K 0.04%
+7,090
New +$499K
SNPS icon
508
Synopsys
SNPS
$78.8B
$498K 0.04%
+1,009
New +$570K
SCHD icon
509
Schwab US Dividend Equity ETF
SCHD
$107B
$496K 0.04%
18,170
-3,684
-17% -$101K
ALAB icon
510
Astera Labs
ALAB
$55B
$492K 0.04%
2,512
-7,303
-74% -$1.2M
MTSI icon
511
MACOM Technology Solutions
MTSI
$22.7B
$492K 0.04%
+3,950
New +$521K
BLDR icon
512
Builders FirstSource
BLDR
$7.74B
$485K 0.04%
4,003
+1,439
+56% +$191K
SPY icon
513
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$810B
$485K 0.04%
1,162
-274
-19% -$176K
JJSF icon
514
J&J Snack Foods
JJSF
$1.68B
$481K 0.04%
+5,001
New +$554K
SMCI icon
515
Super Micro Computer
SMCI
$20.4B
$479K 0.04%
10,000
-14,593
-59% -$697K
CCRD
516
DELISTED
CoreCard
CCRD
$476K 0.04%
+17,684
New +$489K
ATRO icon
517
Astronics
ATRO
$3.72B
$475K 0.04%
12,499
-55,345
-82% -$1.68M
RPD icon
518
Rapid7
RPD
$776M
$471K 0.04%
25,101
-2,270
-8% -$48K
PRCT icon
519
Procept Biorobotics
PRCT
$1.24B
$470K 0.04%
+13,176
New +$602K
MA icon
520
Mastercard
MA
$493B
$470K 0.04%
826
+185
+29% +$106K
PNW icon
521
Pinnacle West Capital
PNW
$12B
$470K 0.04%
+5,240
New +$472K
ORLA
522
DELISTED
Orla Mining
ORLA
$463K 0.04%
+42,861
New +$459K
NWE icon
523
NorthWestern Energy
NWE
$4.38B
$459K 0.04%
+7,824
New +$432K
FNB icon
524
FNB Corp
FNB
$6.75B
$456K 0.04%
28,280
+10,354
+58% +$165K
CPB icon
525
Campbell Soup
CPB
$6.69B
$455K 0.04%
14,420
+7,345
+104% +$237K
19 20
21
22 23

Similar funds

PFBT
Parkside Financial Bank & Trust Saint Louis, Missouri $1.31B AUM 19.14% 1-Year Est. Return
CCP
Clarkston Capital Partners Rochester, Michigan $1.31B AUM 3.79% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Prelude Capital Management's Q3 2025 Portfolio in Review

As of Q3 2025, Prelude Capital Management held 1,446 positions worth $1.28B, up 25% from $1.03B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Prelude Capital Management deployed $143M of net new capital in Q3 2025, opening 471 new positions and adding to 321 existing holdings. Its largest new stake was Verona Pharma: 160,565 shares worth $17.1M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Communication Services and Healthcare.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $13.2M trimmed.

  • Prelude Capital Management's largest Q3 2025 buy was Verona Pharma: 160,565 shares worth $17.1M.
  • Prelude Capital Management added most to Amazon in Q3 2025, an estimated $11.4M increase.
  • Prelude Capital Management's biggest Q3 2025 reduction was Meta Platforms (Facebook), cutting an estimated $13.2M.
  • Prelude Capital Management fully exited Amedisys in Q3 2025, selling an estimated $8.89M.
  • Prelude Capital Management's ten largest holdings make up 13% of its $1.28B portfolio in Q3 2025.
  • Prelude Capital Management opened 471 new positions and closed 327 in Q3 2025.
  • Prelude Capital Management's portfolio value rose 25% quarter-over-quarter to $1.28B.

Based on Prelude Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.